Evidence map›Paper›PMID 27881399›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2017

Intradermal administration of endothelin-1 attenuates endothelium-dependent and -independent cutaneous vasodilation via Rho kinase in young adults.

Naoto Fujii, Tatsuro Amano, Lyra Halili, Jeffrey C Louie, Sarah Y Zhang, Brendan D McNeely, Glen P Kenny

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Naoto FujiiHuman and Environmental Physiology Research Unit, University of Ottawa, Ottawa, Canada; and.
Tatsuro AmanoLaboratory for Exercise and Environmental Physiology, Faculty of Education, Niigata University, Niigata, Japan.
Lyra HaliliHuman and Environmental Physiology Research Unit, University of Ottawa, Ottawa, Canada; and.
Jeffrey C LouieHuman and Environmental Physiology Research Unit, University of Ottawa, Ottawa, Canada; and.
Sarah Y ZhangHuman and Environmental Physiology Research Unit, University of Ottawa, Ottawa, Canada; and.
Brendan D McNeelyHuman and Environmental Physiology Research Unit, University of Ottawa, Ottawa, Canada; and.
Glen P KennyHuman and Environmental Physiology Research Unit, University of Ottawa, Ottawa, Canada; and gkenny@uottawa.ca.
University of Ottawa · CANiigata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently showed that intradermal administration of endothelin-1 diminished endothelium-dependent and -independent cutaneous vasodilation. We evaluated the hypothesis that Rho kinase may be a mediator of this response. We also sought to evaluate if endothelin-1 increases sweating. In 12 adults (25 ± 6 yr), we measured cutaneous vascular conductance (CVC) and sweating during 1) endothelium-dependent vasodilation induced via administration of incremental doses of methacholine (0.25, 5, 100, and 2,000 mM each for 25 min) and 2) endothelium-independent vasodilation induced via administration of 50 mM sodium nitroprusside (20-25 min). Responses were evaluated at four skin sites treated with either 1) lactated Ringer solution (Control), 2) 400 nM endothelin-1, 3) 3 mM HA-1077 (Rho kinase inhibitor), or 4) endothelin-1+HA-1077. Pharmacological agents were intradermally administered via microdialysis. Relative to the Control site, endothelin-1 attenuated endothelium-dependent vasodilation (CVC at 2,000 mM methacholine, 80 ± 10 vs. 56 ± 15%max, P < 0.01); however, this response was not detected when the Rho kinase inhibitor was simultaneously administered (CVC at 2,000 mM methacholine for Rho kinase inhibitor vs. endothelin-1 + Rho kinase inhibitor sites: 73 ± 9 vs. 72 ± 11%max, P > 0.05). Endothelium-independent vasodilation was attenuated by endothelin-1 compared with the Control site (CVC, 92 ± 13 vs. 70 ± 14%max, P < 0.01). However, in the presence of Rho kinase inhibition, endothelin-1 did not affect endothelium-independent vasodilation (CVC at Rho kinase inhibitor vs. endothelin-1+Rho kinase inhibitor sites: 81 ± 9 vs. 86 ± 10%max, P > 0.05). There was no between-site difference in sweating throughout (P > 0.05). We show that in young adults, Rho kinase is an important mediator of the endothelin-1-mediated attenuation of endothelium-dependent and -independent cutaneous vasodilation, and that endothelin-1 does not increase sweating.

Indexed as

Administration, CutaneousAdultBlood Flow VelocityDose-Response Relationship, DrugEndothelin-1Endothelium, VascularFemaleHumansMalerho-Associated KinasesSkinSweatingTreatment OutcomeVasoconstrictor AgentsVasodilationEndothelin-1rho-Associated KinasesVasoconstrictor Agentsendothelial cellmicrocirculationROCKvascular smooth muscle cell

Identifiers

PMID27881399
PMCPMC5283942
OpenAlexW2549740905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.